Arshat Urazbaev

Arshat Urazbaev


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2026 in Electronic Journal of General Medicine
Verified
Journal Article
Closed access
AUArshat Urazbaev
Arshat Urazbaev
BIBakytzhan Amangeldinovna Issakhanova
Bakytzhan Amangeldinovna Issakhanova
Zhanas BaimagambetZhanas Baimagambet
Zhanas Baimagambet
ZRZamart Ramazanova
Zamart Ramazanova
YBYeldar Baiken
Yeldar Baiken
Askhat MyngbayAskhat Myngbay
Askhat Myngbay
Objectives: Automation of quantitative analysis of breast cancer (BC) immunohistochemistry (IHC) specimens is important to optimize pathologists’ workflow and improve diagnostic reproducibility. This is especially important in low- and middle-income countries where there is a shortage of highly trained pathologists. However, existing approaches face challenges in implementing fully automated quantitative IHC due to the difficulty of both delineating tumor areas, including discrete areas, especially in IHC slides with poor quality. Moreover, accurate identification of invasive carcinoma areas and accurate quantification of positive and negative cells in the specimen are critical for quantitative analysis. Methods and results: This study presents a method to automatically identify types of carcinoma areas in whole slide IHC images of BC, focusing on quantifying IHC images on realms of Kazakhstan. The used model is a combination of morphological characteristics and boundary features, which provides high accuracy of segmentation of tumor zones of images of mild and low quality. We used several methods includes convolutional neural network based on the Keras framework, k-nearest neighbors machine learning methods, and self-developed image analysis methods. The developed model showed high accuracy, where the results corresponded to the diagnoses of pathologists. As expected, the method proved to be ineffective when applied to severely degraded slides, such as those with insufficient staining or inadequate washing. Slides of inferior quality were excluded from analysis, which negatively affected the statistical robustness. On slides of moderate quality, the reliability of nucleus segmentation dropped significantly. Conclusions: The combination of models we used showed high accuracy in differentiating BC cells between the basal-like subtype of BC and its invasiveness and recurrence in Kazakhstan. However, IHC specimens with low DPI or low-quality IHC need further optimizations and improvements in algorithm design. The main issue can be considered methodological differences between the approaches of AI and humans: AI operates in a large number of cases (more than 10,000), yet its accuracy is relatively low. In contrast, humans work with a much smaller number of cases but achieve a level of precision that AI cannot currently match. This discrepancy necessitates a revision of the methodology of IHC analysis for AI, including the development of new requirements, methods, and thresholds from scratch. This approach provides analysis of the entire area of the slide, increases the speed of interpretation of IHC results, and reduces human errors in diagnosis, especially in low- and middle-income countries.

30 October 2025 in Scientific Journal of Astana IT University
Verified
Journal Article
Open access
PDF file
ZRZamart Ramazanova
Zamart Ramazanova
YBYeldar Baiken
Yeldar Baiken
BMBakhyt Turganbayevich Matkarimov
Bakhyt Turganbayevich Matkarimov
AUArshat Urazbaev
Arshat Urazbaev
Askhat MyngbayAskhat Myngbay
Askhat Myngbay
BABauyrzhan Aituov
Bauyrzhan Aituov
Breast cancer continues to be the most encountered malignancy in women globally and a leading cause of cancer-related mortality. This study describes an Information Technology approach to evaluate interpretable machine-learning methods for breast cancer prediction using routine clinical data and to situate performance against prior literature. All calculations are based on the Breast Cancer Wisconsin Diagnostic dataset (569 instances; malignant/benign labels) hosted by the UCI Machine Learning Repository. Each sample corresponds to a breast mass classified as malignant or benign. Four supervised machine learning models were applied: Logistic Regression with L1 penalty, Random Forest, Decision Tree, and Naïve Bayes, and compared the area under the ROC curve (AUC), accuracy, sensitivity, and specificity using DeLong’s test with Holm correction. The reproducible pipeline consisted of preprocessing, recursive feature elimination for feature selection, and a 5-fold cross-validation for hyperparameter tuning. Among the four models, the L1-penalized Logistic Regression yielded the best results, with an AUC indicating accuracy, sensitivity, and specificity of 99.6% (97.3%, 95.2%, 98.6%) on the test sets, respectively. This study illustrates the effective integration of supervised machine learning methods into diagnostic systems to produce early, accurate, interpretable diagnoses of disease. This study reinforces the proposed information technology approach for breast cancer prognosis. Limitations of the study are a moderately sized, homogeneous cohort, and restricted focus on structured variables, which may enhance internal validity while restricting generalizability. Our findings contribute to an emerging body of literature that well-tuned, regularized logistic regression provides a reasonable baseline against which breast cancer risk and other study outcomes can be compared, and a pragmatic route toward trustworthy AI in oncology.